Ballston Spa Bancorp, Inc. financials

BSPA CIK 0002094107

Source: EDGAR filings · Built 2026-08-18T00:16:11Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Free Cash Flow -926.00K -1.42M 242.00K 29.00K
Return on Equity (ROE) -0.75% 0.35% 1.79% 1.92%
Return on Assets (ROA) -0.05% 0.03%
Effective Tax Rate 36.29% 48.85% 19.02% 18.99%
Cash Conversion Ratio -0.79× -2.41× 0.89× 0.41×
Accruals Ratio -0.00× 0.00×
CapEx Coverage 0.38× -0.70× 1.28× 1.06×
Free Cash Flow Per Share $-0.85 $-1.93 $0.33 $0.04

Income Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Income Tax Expense (Benefit) -405.00K 233.00K 290.00K 305.00K
Net Income (Loss) Attributable to Parent -711.00K 244.00K 1.24M 1.30M
Earnings Per Share, Basic $-0.65 $0.33 $1.66 $1.75
Weighted Average Number of Shares Outstanding, Basic 1.10M 742,663 742,663 742,663

Balance Sheet

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Cash and Cash Equivalents, at Carrying Value 93.14M 47.82M 28.15M
Assets 1.36B 941.57M 928.50M
Liabilities 1.27B 870.90M 857.36M
Stockholders' Equity Attributable to Parent 94.89M 70.67M 71.14M 69.08M 67.81M

Cash Flow Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Net Cash Provided by (Used in) Operating Activities 560.00K -588.00K 1.10M 539.00K
Payments to Acquire Property, Plant, and Equipment 1.49M 836.00K 862.00K 510.00K
Net Cash Provided by (Used in) Investing Activities 134.03M 6.55M -16.86M -2.09M
Payments of Dividends 617.00K 245.00K 490.00K 245.00K
Net Cash Provided by (Used in) Financing Activities -69.59M 13.71M 13.65M 1.30M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (BSPA CIK 0002094107), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IDYA

IDEAYA Biosciences, Inc.

RYTM

RHYTHM PHARMACEUTICALS, INC.

BEAG

BOLD EAGLE ACQUISITION CORP.